Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinician Decision Making Regarding Surveillance for Low-risk Intraductal Papillary Mucinous Neoplasms of The Pancreas

NCT06311032 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT06311032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06311032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinician Decision Making Regarding Surveillance for Low-risk Intraductal Papillary Mucinous Neoplasms of The Pancreas
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Completed
Start date
March 29, 2023
Completion date
July 28, 2023
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

surgery risk assessment